Mackenzie Financial Corp Assembly Biosciences, Inc. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 15, 2018	SELL	$34.41 - $44.23 $240,869 - $309,610	-7,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$41.7 - $64.16 $397,192 - $611,124	-9,525 Reduced 57.64%	7,000 $344,000
Q3 2017 Nov 13, 2017	BUY	$23.08 - $34.92 $381,397 - $577,053	16,525	16,525 $577,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.